Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase

Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase Distribution agreement and capital increase: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in 2017 and the company remains on track with its development plan to deliver […]